Edition:
United States

Soleno Therapeutics Inc (SLNO.OQ)

SLNO.OQ on NASDAQ Stock Exchange Capital Market

2.10USD
11:36am EDT
Change (% chg)

$-0.03 (-1.41%)
Prev Close
$2.13
Open
$2.15
Day's High
$2.17
Day's Low
$2.10
Volume
1,029
Avg. Vol
31,140
52-wk High
$3.60
52-wk Low
$1.35

Chart for

About

Soleno Therapeutics, Inc., formerly Capnia, Inc., is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon... (more)

Overall

Beta: 4.78
Market Cap(Mil.): $45.61
Shares Outstanding(Mil.): 21.41
Dividend: --
Yield (%): --

Financials

  SLNO.OQ Industry Sector
P/E (TTM): -- 39.51 32.69
EPS (TTM): -0.08 -- --
ROI: -23.04 14.13 12.72
ROE: -32.33 17.35 14.85

BRIEF-Soleno Therapeutics Q1 Loss Per Share $0.19

* SOLENO THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 16 2018

BRIEF-Soleno Therapeutics Says QTRLY Loss Per Share From Continuing Operations $0.17 - SEC Filing

* SOLENO THERAPEUTICS SAYS QTRLY LOSS PER SHARE FROM CONTINUING OPERATIONS $0.17 - SEC FILING

May 16 2018

BRIEF-Soleno Therapeutics Announces Initiation Of Phase III Clinical Trial Of DCCR In Prader-Willi Syndrome

* SOLENO THERAPEUTICS ANNOUNCES INITIATION OF PHASE III CLINICAL TRIAL OF DCCR IN PRADER-WILLI SYNDROME

May 14 2018

BRIEF-Soleno Therapeutics Reports Q4 Loss Per Share $0.43

* Q4 LOSS PER SHARE $0.39 FROM CONTINUING OPERATIONS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

Apr 02 2018

Earnings vs. Estimates